Ellevest Inc’s Co-Diagnostics CODX Stock Holding History

Ellevest Inc’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	-$1K	–	1211
2020 Q3	$1K	Buy	+2	New	+$1.03K	﹤0.01%	981

Other funds holding CODX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ellevest Inc's CODX Position: Q4 2020 in Review

Ellevest Inc sold out of Co-Diagnostics (CODX) in Q4 2020, closing a stake of 2 shares — an estimated $1K sold.

Ellevest Inc first reported a position in CODX in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 83 funds tracked by Wall St. Rank hold CODX as of Q4 2020.

Ellevest Inc reported no remaining Co-Diagnostics position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 2 Co-Diagnostics shares in Q4 2020, an estimated $1K.
Ellevest Inc first reported a position in Co-Diagnostics in Q3 2020 and held it in 1 quarter.
Ellevest Inc's Co-Diagnostics position peaked at $1K in Q3 2020.
83 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.